James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 1,200,000 shares at $25.00 ($30.0M) on 2017-06-22, disclosed to the SEC on 2017-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |